The Quality Assurance Officer will have responsibility for acting as one of the QA Officers for the Positron Emitting Radiopharmaceutical Laboratory (PERL). QA duties will focus on being a key point of contact between QA and the PERL radiochemistry team and external stakeholders whilst undertaking QA tasks in support of the PERL.

The PET Centre is part of Guys & St Thomas NHS Foundation Trust GSTT and Kings College London KCL within the School of Biomedical Engineering & Imaging Sciences.

The Positron Emitting Radiopharmaceutical Laboratory PERL plays a crucial role in the clinical PET Centre, serving over 8,000 patients and research participants annually from South-East London and beyond. It is an integral part of both King's College London's School of Biomedical Engineering and Imaging Sciences and Guy's and St Thomas' National Health Service NHS Foundation Trust. Our PET Center relies heavily on the PERL facility for the supply of radiopharmaceuticals and this is likely to become increasingly important when the new Total Body PET scanner is installed later this year.

Comprising two GMP clean rooms, a QC laboratory, and an R&D laboratory with a total of 24 hot cells, the PERL facility is equipped with a PETtrace high-energy cyclotron and various dispensing units, calibrators, and analysis equipment. It operates under a Specials manufacturing license, currently producing 18Ffluorodeoxyglucose FDG and 11Cmethionine routinely, with ongoing development of additional radiotracers. We anticipate the availability of two more radiotracers for routine and research use by the end of 2024, with plans to expand the portfolio by two to three radiotracers annually.

£53,149 to £62,422 a year King's Grade 7, including LWA